Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries
Vext Science (VEXTF) has completed the acquisition of two cannabis dispensaries from Big Perm's Dispensary Ohio for US$8.1 million, doubling its retail presence in Ohio. The acquisition adds locations in Athens and Jeffersonville to existing dispensaries in Jackson and Columbus.
The company is now fully vertically integrated in Ohio with:
- A Tier I cultivation facility (25,000 sq ft, expandable to 50,000 sq ft)
- A manufacturing facility
- Four operational medical and adult-use dispensaries
Vext has secured approval to develop three additional dual-use dispensaries and expects its Portsmouth location to commence operations in Q2/Q3 2025. The company is on track to reach Ohio's state license cap of eight dispensaries by early 2026, with cash flow projected to return to growth in Q4 2024.
Vext Science (VEXTF) ha completato l'acquisizione di due dispensari di cannabis da Big Perm's Dispensary Ohio per 8,1 milioni di dollari, raddoppiando la sua presenza al dettaglio in Ohio. L'acquisizione aggiunge sedi ad Athens e Jeffersonville ai dispensari esistenti a Jackson e Columbus.
L'azienda è ora completamente integrata verticalmente in Ohio con:
- Una struttura di coltivazione di livello I (25.000 piedi quadrati, espandibile a 50.000 piedi quadrati)
- Una struttura di produzione
- Quattro dispensari operativi per uso medico e per adulti
Vext ha ottenuto l'approvazione per sviluppare tre ulteriori dispensari a uso doppio e prevede che la sua sede di Portsmouth avvii le operazioni nel secondo o terzo trimestre del 2025. L'azienda è sulla buona strada per raggiungere il limite di licenze statali dell'Ohio di otto dispensari entro l'inizio del 2026, con un flusso di cassa previsto in crescita nel quarto trimestre del 2024.
Vext Science (VEXTF) ha completado la adquisición de dos dispensarios de cannabis de Big Perm's Dispensary Ohio por 8,1 millones de dólares, duplicando su presencia minorista en Ohio. La adquisición añade ubicaciones en Athens y Jeffersonville a los dispensarios existentes en Jackson y Columbus.
La empresa ahora está completamente integrada verticalmente en Ohio con:
- Una instalación de cultivo de Nivel I (25,000 pies cuadrados, ampliable a 50,000 pies cuadrados)
- Una instalación de manufactura
- Cuatro dispensarios operativos para uso médico y de adultos
Vext ha obtenido la aprobación para desarrollar tres dispensarios de uso dual adicionales y espera que su ubicación en Portsmouth comience a operar en el segundo o tercer trimestre de 2025. La empresa está en camino de alcanzar el límite de licencias estatales de Ohio de ocho dispensarios a principios de 2026, con un flujo de caja proyectado para volver a crecer en el cuarto trimestre de 2024.
Vext Science (VEXTF)는 Big Perm's Dispensary Ohio로부터 810만 달러에 두 개의 대마초 매장을 인수하여 오하이오에서의 소매 존재를 두 배로 늘렸습니다. 이번 인수로 잭슨과 콜럼버스에 있는 기존 매장에 아테네와 제퍼슨빌 매장이 추가되었습니다.
회사는 이제 오하이오에서 완전히 수직 통합되어 있으며:
- 1급 재배 시설 (25,000 평방 피트, 50,000 평방 피트로 확장 가능)
- 제조 시설
- 운영 중인 의료 및 성인용 매장 4곳
Vext는 추가적인 이중 사용 매장 3곳을 개발할 수 있는 승인을 받았으며, 포츠머스 위치가 2025년 2분기/3분기에 운영을 시작할 것으로 예상하고 있습니다. 이 회사는 2026년 초까지 오하이오의 주 면허 한도인 8개의 매장에 도달할 예정이며, 2024년 4분기에는 현금 흐름이 다시 성장할 것으로 예상하고 있습니다.
Vext Science (VEXTF) a finalisé l'acquisition de deux dispensaires de cannabis de Big Perm's Dispensary Ohio pour 8,1 millions de dollars, doublant ainsi sa présence au détail dans l'Ohio. L'acquisition ajoute des emplacements à Athens et Jeffersonville aux dispensaires existants à Jackson et Columbus.
L'entreprise est désormais entièrement intégrée verticalement dans l'Ohio avec:
- Une installation de culture de niveau I (25 000 pieds carrés, extensible à 50 000 pieds carrés)
- Une installation de fabrication
- Quatre dispensaires opérationnels pour usage médical et adulte
Vext a obtenu l'approbation pour développer trois autres dispensaires à usage double et s'attend à ce que son emplacement à Portsmouth commence ses opérations au deuxième ou troisième trimestre 2025. L'entreprise est sur la bonne voie pour atteindre le plafond de licences d'État de l'Ohio de huit dispensaires d'ici début 2026, avec un flux de trésorerie prévu pour revenir à la croissance au quatrième trimestre 2024.
Vext Science (VEXTF) hat die Übernahme von zwei Cannabis-Dispensaries von Big Perm's Dispensary Ohio für 8,1 Millionen US-Dollar abgeschlossen und damit seine Einzelhandelspräsenz in Ohio verdoppelt. Die Übernahme fügt Standorte in Athens und Jeffersonville zu den bestehenden Dispensiaren in Jackson und Columbus hinzu.
Das Unternehmen ist jetzt vollständig vertikal integriert in Ohio mit:
- Eine Tier I Anbauanlage (25.000 Quadratfuß, erweiterbar auf 50.000 Quadratfuß)
- Eine Produktionsstätte
- Vier betriebsbereite medizinische und Freizeit-Dispensaries
Vext hat die Genehmigung erhalten, drei weitere Dual-Use-Dispensaries zu entwickeln, und erwartet, dass der Standort in Portsmouth im 2. oder 3. Quartal 2025 in Betrieb gehen wird. Das Unternehmen ist auf dem besten Weg, die staatliche Lizenzobergrenze von acht Dispensiaren in Ohio bis Anfang 2026 zu erreichen, wobei der Cashflow im 4. Quartal 2024 voraussichtlich wieder wachsen wird.
- Doubled retail footprint from 2 to 4 dispensaries in Ohio's -license market
- Secured approval for 4 additional dispensaries, reaching state maximum of 8
- Full vertical integration with cultivation, manufacturing, and retail operations
- Cash flow expected to return to growth in Q4 2024
- Cultivation facility can expand from 25,000 to 50,000 square feet
- Significant cash expenditure of US$8.1 million for acquisition
- Extended timeline to reach full dispensary capacity (early 2026)
- Regulatory approvals still pending for Portsmouth location
- Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open during 2025 and early 2026.
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertically integrated operations in Arizona and Ohio, today announced that it has completed the acquisition of two cannabis dispensaries from Big Perm's Dispensary Ohio, LLC ("Big Perm") together with all related licenses and assets, other than certain excluded assets (the "Ohio Expansion Transaction"), following receipt of the regulatory approval from Ohio Division of Cannabis Control ("DCC"). The Company has paid aggregate cash consideration of approximately US
Eric Offenberger, CEO of Vext, commented, "Today's announcement marks a significant step forward in Vext's strategic expansion within Ohio's limited-license market. With four operational dispensaries and a clear path to reaching the state license cap of eight, we are building a retail footprint that is designed to generate consistent cash flow. A strong retail presence enables us to better control our distribution and align it with our cultivation and manufacturing assets - a balance that supports long-term profitability. The remaining four Vext dispensaries are scheduled to come online in 2025 and early 2026 as we execute on our disciplined strategy. With cash flow returning to growth in Q4 2024, and a clear path to further expansion in Ohio during 2025 and beyond, Vext is on a path that we expect will create meaningful long-term value for our shareholders."
Already fully vertically integrated in Ohio with a Tier I cultivation facility, a manufacturing facility, and now four strategically located retail dispensaries, this transaction further strengthens the Company's presence in the state. With the recently announced Portsmouth location expected to commence operations during Q2 or Q3 of 2025 and license approvals from the DCC for an additional three dispensaries, Vext is on track to reach the state dispensary license cap of eight by early 2026.
Vext's Current Footprint in Ohio:
Facility1 | Status |
Tier 1 Cultivation Facility - 25,000 square feet (Jackson, Ohio) | Fully operational. Ability to expand to 50,000 square feet. Certificate of Operation received for adult-use. |
Manufacturing Facility (Jackson, Ohio) | Fully operational. |
Herbal Wellness Center (Jackson, Ohio) | Fully operational as a medical and adult-use dispensary. |
Herbal Wellness Center (Columbus, Ohio) | Fully operational as a medical and adult-use dispensary. |
Herbal Wellness Center (Athens, Ohio) | Fully operational as a medical and adult-use dispensary. |
Herbal Wellness Center (Jeffersonville, Ohio) | Fully operational as a medical and adult-use dispensary. |
Dispensary 5 (Portsmouth, Ohio) | Additional adult-use license under the DCC's 10(B) license program. With the completion of the Ohio Expansion Transaction, Vext has secured the right to transfer ownership of the Portsmouth dispensary. Pending regulatory and zoning approvals, the Company anticipates executing the transfer and commencing operations by Q2 or Q3 of 2025. |
Dispensaries 6, 7 and 8 (Granted approval to develop 3 additional dual-use dispensaries) | As a Tier 1 Cultivator, Vext has received approval under the DCC's 10(B) license program to develop three additional dual-use dispensaries. Target locations have been identified and will be announced when provisional permits are issued by the DCC. |
For more details, visit Vext's investor website or contact the IR team at investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding future developments and the business and operations of Vext, including but not limited to the Company's anticipated results from operations, the receipt of applicable regulatory approvals, the acquisition of additional licenses, and the development and opening of additional dispensaries in Ohio, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc.
1 Vext has been granted approval to develop dispensaries 6, 7, and 8 under the DCC's 10(B) license program. As noted in the above chart, target locations have been identified but currently there are no associated facilities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247157